Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
-
* Corresponding author: Andrea Morelli andrea.morelli@uniroma1.it
Critical Care 2009, 13:R130 doi:10.1186/cc7990
Accesses
- Last 30 days: 125 accesses
- Last year: 1383 accesses
- All time: 5623 accesses
Cited by
BioMed Central: 5 citations
|
Translational research in sepsis - an ultimate challenge? Tim G Kampmeier, Christian Ertmer, Sebastian Rehberg Experimental & Translational Stroke Medicine 2011, 3:14 (14 November 2011) |
|
Andrea Morelli, Abele Donati, Christian Ertmer, Sebastian Rehberg, Tim Kampmeier, Alessandra Orecchioni, Alessandro Di Russo, Annalia D'Egidio, Giovanni Landoni, Maria Lombrano, Laura Botticelli, Agnese Valentini, Alberto Zangrillo, Paolo Pietropaoli, Martin Westphal Critical Care 2011, 15:R217 (19 September 2011) |
|
Bench-to-bedside review: Vasopressin in the management of septic shock James A Russell Critical Care 2009, 15:226 (11 August 2011) |
|
Year in review 2009: Critical Care - shock Wolfgang Stahl, Hendrik Bracht, Peter Radermacher, Jörg Thomas Critical Care 2010, 14:239 (5 November 2010) |
|
Marc Leone Critical Care 2009, 13:192 (7 October 2009) |